CR1 and cancer: The increasing advances in oligonucleotides optimization and their delivery tools, as well as the approval of several oligonucleotide-based drugs, enables, at least in theory, the modulation of cancer vital genes such as Cr-1 and Nodal. Different miRNAs were found altered in several human cancers.